Search filters

List of works by Helene H Grytli

Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease

scientific article published on 14 January 2013

Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy

scientific article

Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy

scientific article published on 20 February 2018

Low β₂-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism

scientific article published on 5 December 2015

PBX3 is a putative biomarker of aggressive prostate cancer

scientific article published on 7 June 2016

Reply to Chris R. Cardwell, Samy Suissa and Liam J. Murray's letter to the editor re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association between use of β-blockers and prostate cancer-specific survival

scientific article published on 11 April 2013

Role of serum response factor expression in prostate cancer biochemical recurrence

scientific article published on 2 April 2018

Use of β‐blockers is associated with prostate cancer‐specific survival in prostate cancer patients on androgen deprivation therapy

scientific article published on July 20, 2012

β-Adrenergic Receptor Signaling in Prostate Cancer

scientific article